CY1117492T1 - Μεθοδος για την παρασκευη μεδετομιδινης με χλωροακετονη - Google Patents

Μεθοδος για την παρασκευη μεδετομιδινης με χλωροακετονη

Info

Publication number
CY1117492T1
CY1117492T1 CY20161100222T CY161100222T CY1117492T1 CY 1117492 T1 CY1117492 T1 CY 1117492T1 CY 20161100222 T CY20161100222 T CY 20161100222T CY 161100222 T CY161100222 T CY 161100222T CY 1117492 T1 CY1117492 T1 CY 1117492T1
Authority
CY
Cyprus
Prior art keywords
chloroacetone
preparation
medetomidin
medetomidine
dimethylbenzene
Prior art date
Application number
CY20161100222T
Other languages
English (en)
Inventor
Doerwald Florencio Zaragoza
Anna Kulesza
Stephan Elzner
Robert Bujok
Zbigniew Wrobel
Krzysztof Wojciechowski
Original Assignee
Lonza Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47557694&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1117492(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lonza Ltd filed Critical Lonza Ltd
Publication of CY1117492T1 publication Critical patent/CY1117492T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η εφεύρεση αποκαλύπτει μία μέθοδο για την παρασκευή μεδετομιδίνης, ξεκινώντας από 1-βρωμο 2,3-διμεθυλβενζόλιο και χλωροακετόνη.
CY20161100222T 2012-06-28 2016-03-16 Μεθοδος για την παρασκευη μεδετομιδινης με χλωροακετονη CY1117492T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261665510P 2012-06-28 2012-06-28
EP12174102 2012-06-28
EP12188104 2012-10-11
EP12192625 2012-11-14
EP12787007.9A EP2867211B1 (en) 2012-06-28 2012-11-15 Method for preparation of medetomidine with chloroacetone

Publications (1)

Publication Number Publication Date
CY1117492T1 true CY1117492T1 (el) 2017-04-26

Family

ID=47557694

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100222T CY1117492T1 (el) 2012-06-28 2016-03-16 Μεθοδος για την παρασκευη μεδετομιδινης με χλωροακετονη

Country Status (21)

Country Link
US (2) US9156793B2 (el)
EP (1) EP2867211B1 (el)
JP (1) JP5777841B2 (el)
KR (1) KR101560116B1 (el)
CN (2) CN105218453B (el)
AU (1) AU2012285677B2 (el)
CA (1) CA2866437C (el)
CL (2) CL2014002907A1 (el)
CY (1) CY1117492T1 (el)
DK (1) DK2867211T3 (el)
EA (1) EA027921B1 (el)
ES (1) ES2565066T3 (el)
HK (2) HK1201530A1 (el)
HR (1) HRP20160216T1 (el)
HU (1) HUE027382T2 (el)
IN (1) IN2014DN07984A (el)
MY (1) MY165218A (el)
PL (1) PL2867211T3 (el)
SG (1) SG11201405609WA (el)
TW (2) TWI560182B (el)
WO (1) WO2013011157A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA025591B1 (ru) 2012-05-08 2017-01-30 Лонца Лтд. Способ получения 2-(2,3-диметилфенил)-1-пропанала
IN2014DN07983A (el) 2012-05-08 2015-05-01 Lonza Ag
PL2867195T3 (pl) * 2012-06-28 2016-06-30 Lonza Ag Sposób wytwarzania 2-(2,3-dimetylofenylo)-1-propanalu przy pomocy chloroacetonu
IN2014DN07984A (el) * 2012-06-28 2015-05-01 Lonza Ag
US11190381B2 (en) * 2016-02-12 2021-11-30 Sony Corporatton Apparatus and method
CN106518812A (zh) * 2016-10-25 2017-03-22 湖南大学 一种美托咪定及其中间体的制备方法
CN113044857B (zh) * 2020-12-30 2023-05-23 重庆柒兴克米科技有限公司 高收率制取高纯氰化钠或氰化钾的生产工艺
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE23400E (en) 1951-08-14 Electkic low and high-voltage fuses
BE790604A (fr) 1971-10-28 1973-04-26 Sandoz Sa Nouveaux aminoalcanols, leur preparation et leur application comme medicaments
JPS51100041A (en) 1975-02-26 1976-09-03 Kanebo Ltd 22 * 44 isobuchirufueniru * puropionsanno seizoho
JPS51100042A (en) 1975-02-26 1976-09-03 Kanebo Ltd 22 * 44 isobuchirufueniru * puropionsanno seizoho
GB2092569B (en) 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
ATE78722T1 (de) 1984-02-24 1992-08-15 Sagami Chem Res Methode zum isomerisieren eines glycidats.
JPS62103037A (ja) * 1985-10-29 1987-05-13 Hamari Yakuhin Kogyo Kk ２−（４−イソブチルフエニル）−プロピオンアルデヒドの製造法
DE19714042A1 (de) 1997-04-05 1998-10-08 Henkel Kgaa Verfahren zur Herstellung aromatischer Aldehyde
SE513474C2 (sv) 1999-01-25 2000-09-18 Hans Elwing Instutionen Foer C Metod för att förhindra kräftdjurs, särskilt havstulpaners, etablering på fasta ytor med hjälp av en substans som stör nervsignaler, varvid substansen är medetomidin, dvs (+)-4-/1- (2,3-dimetylfenyl)-etyl/-IH-imidazol
EP1918282A1 (en) * 2006-11-06 2008-05-07 "Joint Stock Company Grindeks" Method for preparing medetomidine and its salts
GB2453982B (en) 2007-10-24 2009-09-16 Norbrook Lab Ltd Chemical process for the preparation of Medetomidine
US7902247B2 (en) 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
CN101921234B (zh) * 2009-06-12 2012-05-30 中国中化股份有限公司 一种制备美托咪啶的方法
WO2011070069A1 (en) * 2009-12-09 2011-06-16 I-Tech Ab Process for preparation of medetomidine
IN2014DN07983A (el) * 2012-05-08 2015-05-01 Lonza Ag
WO2012172120A2 (en) 2012-05-08 2012-12-20 Lonza Ltd 2-(2,3-dimethylphenyl)-1-propanal and its use as perfume
WO2012172119A2 (en) * 2012-05-08 2012-12-20 Lonza Ltd Method for the preparation of medetomidine
EA025591B1 (ru) * 2012-05-08 2017-01-30 Лонца Лтд. Способ получения 2-(2,3-диметилфенил)-1-пропанала
WO2012172121A1 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of medetomidine with chloroacetone
PL2867195T3 (pl) * 2012-06-28 2016-06-30 Lonza Ag Sposób wytwarzania 2-(2,3-dimetylofenylo)-1-propanalu przy pomocy chloroacetonu
WO2012172122A2 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal
IN2014DN07984A (el) * 2012-06-28 2015-05-01 Lonza Ag

Also Published As

Publication number Publication date
TW201402553A (zh) 2014-01-16
US9156793B2 (en) 2015-10-13
US9434694B2 (en) 2016-09-06
CA2866437C (en) 2018-01-02
EP2867211B1 (en) 2015-12-30
EA027921B1 (ru) 2017-09-29
IN2014DN07984A (el) 2015-05-01
JP2015517474A (ja) 2015-06-22
AU2012285677B2 (en) 2016-03-31
PL2867211T3 (pl) 2016-06-30
HK1201530A1 (zh) 2015-09-04
US20150099889A1 (en) 2015-04-09
JP5777841B2 (ja) 2015-09-09
TW201630888A (zh) 2016-09-01
SG11201405609WA (en) 2015-02-27
DK2867211T3 (en) 2016-02-29
CA2866437A1 (en) 2013-01-24
CL2014002907A1 (es) 2015-01-16
US20150336909A1 (en) 2015-11-26
EA201400939A1 (ru) 2015-01-30
NZ700642A (en) 2016-04-29
CN104245678A (zh) 2014-12-24
TWI560182B (en) 2016-12-01
CN104245678B (zh) 2016-02-24
KR101560116B1 (ko) 2015-10-13
WO2013011157A1 (en) 2013-01-24
CL2016001664A1 (es) 2017-01-27
CN105218453B (zh) 2017-04-12
HUE027382T2 (en) 2016-10-28
KR20140129399A (ko) 2014-11-06
TWI543970B (zh) 2016-08-01
EP2867211A1 (en) 2015-05-06
HRP20160216T1 (hr) 2016-03-25
ES2565066T3 (es) 2016-03-31
AU2012285677A1 (en) 2014-09-25
CN105218453A (zh) 2016-01-06
MY165218A (en) 2018-03-09
HK1213893A1 (zh) 2016-07-15

Similar Documents

Publication Publication Date Title
CY1122398T1 (el) Συνδυαστικες θεραπειες με αντισωματα anti-cd38
CY1117491T1 (el) Μεθοδος για την παρασκευη 2-(2,3-διμεθυλφαινυλ)-1-προπαναλης με χλωροακετονη
CY1124004T1 (el) Υποδορια σκευασματα αντισωματων αντι-cd38 και οι χρησεις τους
CY1117492T1 (el) Μεθοδος για την παρασκευη μεδετομιδινης με χλωροακετονη
TR201905829T4 (tr) Buzdolabı.
CR20140529A (es) Anticuerpos e inmunoconjugados contra ly6e y métodos de uso
CO7151527A2 (es) Anticuerpos anti-cd79 b e inmunoconjugados
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
UY34817A (es) Tienopirimidinas
BR112017012364A2 (pt) pré-tratamento rápido.
EA201400940A1 (ru) Способ получения медетомидина
UY4153Q (es) Batería
CY1117404T1 (el) Μεθοδος παρασκευης 2-(2,3-διμεθυλφαινυλ)-1-προπαναλης
EA201700142A1 (ru) Полимерная композиция для слоя элемента слоя
UY4430S (es) “motocicleta”.
TR201906399T4 (tr) Kapali döngülü soğutma si̇stemi̇ne sahi̇p elektri̇kli̇ pompa
BR112017023854A2 (pt) estator.
UY34677A (es) Imidazopiridazinas sustituidas
UY4152Q (es) Batería
SE1530091A1 (el)
ES1147283Y (es) Dispositivo generador de energía eléctrica.
ES1124406Y (es) Pieza de hormigón luminiscente.
FR3022490B1 (fr) Renfort, metallique ou metallise, graphenise
CL2017002907S1 (es) Calefactor de inducción.
UA111656C2 (uk) Спосіб одержання медетомідину з використанням хлорацетону